USFDA - HealthQuill

Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million government funding to expand its clinical trial capabilities, according to the company.

Walgreens grabs $100 million from US government for decentralized trials

Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million government funding to expand its clinical.

by HealthQuill
August 20, 2024
0 Comments

ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and paediatric patients.

Drugs Health Pharma

US-based ARS’s nasal spray to treat allergic reactions gets FDA nod

ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.

by HealthQuill
August 12, 2024
0 Comments

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.

Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.

by HealthQuill
August 12, 2024
0 Comments

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare form of blood cancer that affects the skin.

Drugs Health Pharma

Citius’s blood cancer drug gets US regulatory body’s clearance

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.

by HealthQuill
August 9, 2024
0 Comments

US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.

Drugs Health Pharma

Purdue Pharma’s opioid overdose drug gets US regulator’s nod

US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.

by HealthQuill
August 8, 2024
0 Comments

Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of patients with a rare type of kidney disease.

Drugs Health Pharma

Novartis’s drug to treat rare kidney disease gets USFDA approval

Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.

by HealthQuill
August 8, 2024
0 Comments

https://investor.g1therapeutics.com/news-releases/news-release-details/fda-approves-g1-therapeutics-coselatm-trilaciclib-first-and-only

Drugs Health Pharma

Denmark’s Pharmacosmos to buy G1 Therapeutics for $405 million

Danish biotechnology company, Pharmacosmos A/S will buy US-based G1 Therapeutics Inc., for $405 million to expand its global commercial portfolio in haematology.